1. Open-label, phase I, pharmacokinetic studies of abiraterone acetate in healthy men;Acharya;Cancer Chemother. Pharmacol.,2012
2. Pancreatic lipase-catalyzed hydrolysis of esters of hydroxymethyl phenytoin dissolved in various metabolizable vehicles, dispersed in micellar systems, and in aqueous suspensions;Alvarez;Pharm. Res.,1989
3. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability;Amidon;Pharm. Res. An Off. J. Am. Assoc. Pharm. Sci.,1995
4. Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven;Attard;J. Clin. Oncol.,2008
5. Drug permeability profiling using cell-free permeation tools: overview and applications;Berben;Eur. J. Pharm. Sci.,2018